Investor Relations

Rights Issue 2025

Rights Issue 2025

The Board of Directors of Integrum AB (publ) (“Integrum” or the “Company”) has today resolved to carry out a share issue of approximately SEK 42.6 million before deduction of issue costs with preferential rights for existing shareholders (the “Rights Issue”). 

Integrum is currently undergoing a transformative journey, from a development-driven company to a streamlined and commercially focused organization. The new strategic direction, which was presented in February 2025, aims to accelerate commercialization through a targeted go-to-market model built around Centers of Excellence. Since the launch of the strategy shift, Integrum has taken important steps to streamline operations, sharpen commercial focus and strengthen financial governance. The progression of the strategy shift and the implementation of cost savings are continuing according to plan and the Company has made progress, but the transformation is not yet complete. To support this transformation, Integrum is executing the Rights Issue. The subscription price is SEK 8.0 per share. The Rights Issue is conditional upon approval by an extraordinary general meeting in the Company, scheduled to be held on November 10, 2025. The Rights Issue is covered to 100 percent through subscription commitments and guarantee commitments. The notice to the extraordinary general meeting will be published through a separate press release. Due to the Rights Issue, the Company’s board of directors has resolved to publish the Company’s Q2 report on November 21, 2025.

Summary of the Rights Issue

  • The net proceeds from the Rights Issue will be used for business development and marketing, personnel and operations, R&D and product development, regulatory and clinical investments, operational efficiency and supply chain flexibility, and to ensure financial stability.
  • The Rights Issue comprises up to 5,333,582 shares of series B with a subscription price of SEK 8.0 per share. If the Rights Issue is fully subscribed, the Company will receive approximately SEK 42.6 million before deduction of costs related to the Rights Issue. 
  • Each share, regardless of series, in the Company held on the record date November 13, 2025 entitles the holder to one (1) subscription right. Four (4) subscription rights entitle the holder to subscribe for one (1) new share of series B.
  • The last day of trading in the Company’s shares including the right to participate in the Rights Issue is November 11, 2025.
  • The subscription period will run from and including November 17, 2025, to and including December 1, 2025.
  • Trading in subscription rights will take place on Nasdaq First North Growth Market during the period from and including November 17, 2025, to and including November 26, 2025, and trading in paid subscribed shares (BTA) will occur during the period from and including November 17, 2025, to and including December 10, 2025. 
  • The Rights Issue is covered by subscription commitments and guarantee commitments corresponding to 100 percent of the issue amount. However, the subscription commitments and the guarantee commitments are not secured by bank guarantees, escrow accounts, pledges or similar arrangements. 
  • The Board of Directors’ resolution on the Rights Issue is subject to approval by an extraordinary general meeting to be held on November 10, 2025. A separate press release with the notice to the extraordinary general meeting will be published through a separate press release. 
  • No prospectus will be prepared in connection with the Rights Issue. The Company will prepare and publish an information document (the “Information Document”) in accordance with Article 1.4 db of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC (the “Prospectus Regulation”).

Extraordinary general meeting

The Board of Directors’ resolution regarding the Rights Issue is subject to approval by an extraordinary general meeting, which is expected to be held on November 10, 2025. Shareholders representing approximately 28.2 percent of the shares and approximately 43.5 percent of the votes in the Company have undertaken or expressed intention to vote in favor of the Rights Issue. Notice of the extraordinary general meeting will be published through a separate press release.

Preliminary time table for the Rights Issue

10 November 2025Extraordinary general meeting
11 November 2025Planned date for publication of the Information Document.
11 November 2025Last day of trading including right to obtain subscription rights.
12 November 2025First day of trading excluding the right to obtain subscription rights.
13 November 2025Record date for participation in the Rights Issue.
17 November – 1 December 2025Subscription period.
17 November – 26 November 2025Trading in subscription rights.
17 November – 10 December 2025Trading in paid subscribed shares (BTA).
2 December 2025Planned date for final disclosure of the outcome of the Rights Issue.
16 December 2025Preliminary first day of trading in new shares.*
*Note that depending on different routines at different banks and custodians the trading may begin before or after this date.

Earlier publication of quarterly report

To enable participation in the Rights Issue by board members, the Company’s board of directors has resolved to publish the Company’s Q2 report on November 21, 2025.

Documents

PR launch of rights issue Information document(SWE) IMPORTANT INFORMATION FOR INVESTORS SUBSCRIPTION WITHOUT SUBSCRIPTION RIGHTS SUBSCRIPTION WITH SUBSCRIPTION RIGHTS STAMMOPROTOKOLL(SWE)